Literature DB >> 24462440

Staphylococcal endocarditis as the first manifestation of heritable protein S deficiency in childhood.

Takayuki Hoshina1, Yasutaka Nakashima2, Daisuke Sato2, Etsuro Nanishi2, Hisanori Nishio2, Hazumu Nagata2, Kenichiro Yamamura2, Takehiko Doi2, Yuichi Shiokawa3, Yui Koga4, Dongchon Kang4, Shouichi Ohga2, Toshiro Hara2.   

Abstract

A 12-year-old Japanese girl developed infective endocarditis and central nervous system disease. The previously healthy girl showed altered consciousness and abnormal behaviors along with the classical signs of septic emboli. Staphylococcus aureus was isolated from peripheral blood, but not, the pleocytotic cerebrospinal fluid. Diagnostic imaging studies revealed a vegetative structure in the morphologically normal heart, and multiple thromboembolisms in the brain and spleen. Low plasma activity of protein S (12%) and thrombophilic family history allowed the genetic study, demonstrating that she carried a heterozygous mutation of PROS1 (exon 13; 1689C > T, p.R474C). Surgical intervention of the thrombotic fibrous organization and subsequent anticoagulant therapy successfully managed the disease. There are no reports of infective endocarditis in childhood occurring as the first presentation of heritable thrombophilia. Protein S deficiency might be a risk factor for the development or exacerbation of infective endocarditis in children having no pre-existing heart disease.
Copyright © 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Infective endocarditis; Protein S deficiency; Staphylococcus aureus; Thromboembolism; Vegetation

Mesh:

Year:  2013        PMID: 24462440     DOI: 10.1016/j.jiac.2013.08.002

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  1 in total

1.  Rapid identification of a pathogenic variant of PROS1 in a thrombophilic family by whole exome sequencing: A case report.

Authors:  Wenwen Zhang; Chen Huang; Wei Zhou
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.